Thromboprophylaxis and Antithrombotic Therapy in Children and Newborns
The article presents the data on physiological characteristics of hemostasis system in children of different age groups. The epidemiological data on the incidence of thromboses and their main causes in children are presented. Indications and schemes of thromboprophylaxis were shown, as well as optimal strategies for the management of thrombosis in children according to international guidelines.
Monagle Р, Chan КС, Goldenberg АN, Ichord NR, Journeycake M. J, Nowak-Göttl U, Vesely S.K. Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. CHEST 2012; 141 (2): e737S – e801S.
Monagle P, Adams M, Mahoney M, Ali K. Outcome of Pediatric Thromboembolic Disease: A Report from the Canadian Childhood Thrombophilia Registry. Pediatric Research 2000; 47: 763–766.
Giglia MT, Massicotte MP, Tweddell JS, Barst RJ. Prevention and Treatment of Thrombosis in Pediatric and Congenital Heart Disease: A Scientific Statement From the American Heart Association. Circulation 2013; 128: 2622-2703.
Andrew M, Paes B, Milner R. Development of the human coagulation system in the full-term infant. Blood 1987; 70: 165–172.
Guzetta NA, Miller BE. Principles of hemostasis in children: models and maturation. Pediatric Anesthesia 2011; 21: 3-10.
Sell EJ, Corrigan JJ. Platelet counts, fibrinogen concentrations and factor V and factor VIII in healthy infants according to gestational age. J Pediatr 1973; 82: 1028–1032.
Copyright (c) 2016 EMERGENCY MEDICINE
This work is licensed under a Creative Commons Attribution 4.0 International License.
© Publishing House Zaslavsky, 1997-2019